Free Trial
NYSE:GMRE

Global Medical REIT Q2 2025 Earnings Report

Global Medical REIT logo
$7.13 -0.03 (-0.42%)
Closing price 07/11/2025 03:59 PM Eastern
Extended Trading
$7.17 +0.04 (+0.56%)
As of 08:18 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Global Medical REIT EPS Results

Actual EPS
N/A
Consensus EPS
$0.23
Beat/Miss
N/A
One Year Ago EPS
N/A

Global Medical REIT Revenue Results

Actual Revenue
N/A
Expected Revenue
$35.57 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Global Medical REIT Announcement Details

Quarter
Q2 2025
Time
Before Market Opens
Conference Call Date
Wednesday, August 6, 2025
Conference Call Time
9:00AM ET

Conference Call Resources

Global Medical REIT Earnings Headlines

GMRE Global Medical REIT Inc. - Seeking Alpha
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Global Medical REIT Names Mark Decker as CEO
Global Medical REIT Appoints Mark Decker, Jr. as CEO
See More Global Medical REIT Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Global Medical REIT? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Global Medical REIT and other key companies, straight to your email.

About Global Medical REIT

Global Medical REIT (NYSE:GMRE) (NYSE: GMRE) is a specialized real estate investment trust focused on owning and operating a diversified portfolio of healthcare properties across North America and select European markets. The company’s primary assets include medical office buildings, outpatient facilities, hospitals, and life science centers. By targeting facilities leased to leading healthcare providers, specialty clinics, and research institutions, Global Medical REIT aims to deliver stable, long-term cash flows under triple-net or modified-net leases, thereby minimizing its operational responsibilities.

Originally launched in 2013 as Physicians Realty Trust, the company has grown through strategic acquisitions, development projects, and joint ventures with medical systems and physician groups. In early 2024, the firm rebranded to Global Medical REIT to reflect its expanding international footprint and broader remit in life science real estate. Today, the company’s portfolio spans more than 150 properties across the United States, Canada, the United Kingdom, Germany, and select Nordic markets, with a focus on high-growth, population-dense regions where demand for modern, specialized healthcare facilities is strongest.

Global Medical REIT’s business model emphasizes disciplined capital allocation and partnership-driven growth. The firm routinely collaborates with health systems, academic medical centers, and private equity sponsors to originate development and redevelopment projects designed to meet evolving industry needs. These initiatives often incorporate telehealth infrastructure, advanced imaging suites, outpatient surgery centers, and pharmaceutical research labs, positioning the portfolio to benefit from trends in ambulatory care and biotechnology innovation.

Headquartered in Dallas, Texas, Global Medical REIT is guided by an executive leadership team with deep expertise in healthcare real estate and financial markets. Chief Executive Officer Joel Neeb, a founding member of the company, is supported by Chief Financial Officer Dennis Garcia and Chief Investment Officer Maria Chen. Together, they oversee asset management, capital markets access, and strategic planning, aiming to enhance portfolio quality and deliver consistent returns for shareholders in a rapidly evolving healthcare landscape.

View Global Medical REIT Profile

More Earnings Resources from MarketBeat